QA: Agile Therapeutics INC in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001261249_2021_Agile_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001261249, Agile Therapeutics INC

  xvar xval
0 AssetsCurrent 56,785,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 14,243,000
3 remainder_Assets 2,034,000
4 LiabilitiesCurrent 7,353,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 16,381,000
7 CostOfGoodsAndServicesSold 282,000
8 SellingGeneralAndAdministrativeExpense 13,205,220
9 ResearchAndDevelopmentExpense 15,927,644
10 remainder_Expenses 13,863,903
11 remainder_Revenues 749,000
12 remainder_NetIncome 217,443
13 remainder_ComprehensiveNetIncome 3,000
  yvar yval
0 Assets 73,062,000
1 Liabilities 23,734,000
2 Expenses 43,278,767
3 Revenues 749,000
4 StockholdersEquity 49,328,000
5 NetIncome -42,312,324
6 ComprehensiveNetIncome -42,310,824
7 BaseVar 70,522,105
8 EconomicCapitalRatiobeforeLimitedLiability 1.35
9 EconomicCapitalRatio 2.57

Edgar->Model Mapping

Feature Distribution

Change over Time